Share

Optalysys and EI demo sequence alignment technology at AGBT

On Wednesday February 15th 2017 at the Advances in Genome Biology and Technology (AGBT) conference in Hollywood Beach, Florida we held a joint demonstration with the Earlham Institute of our optical processing technology performing genetic sequence alignment.

The prototype demonstration showed our co-processor technology performing sequence alignment with 151 base pairs reads against the ecoli genome and outputting the results into a SAM file format which is a widely used format for storing biological sequence alignment data.  It showed the ability of the technology to align partially matched reads and its ability to dynamically switch between BLAST-like and BWA-like outputs.

We attracted a large and enthusiastic audience of bioinformaticians, scientists, biologists and technology vendors who are very keen to see a revolutionary technology come to market to support them in their alignment work.

 

About Optalysys:

Optalysys was founded in 2013 to develop revolutionary optical processing technology for the areas of Big Data processing and complex mathematics.  The first product is launching at the end of 2017 and performs genetic sequence alignment.

Optalysys evolved from a University of Cambridge spin-out known as Cambridge Correlators Limited (CCL) when the team refocused on large scale HPC applications.

The Optalysys team includes specialists in software development, bioinformatics, free-space optics and optical engineering.

The company has several patents covering its groundbreaking technology.

Latest news view all
Optalysys, Ltd. Raises $4 Million Seed Round to Break Bottlenecks in Genomic Research and Big Data Analysis

Light-Speed Optical Processing Startup to Democratize Access to High-Powered Computing and Drive Advances in Research and Development GLASSHOUGHTON, WEST YORKSHIRE, U.K. and RENO, Nev.–September 20, 2017 Optalysys Ltd. (@Optalysys), a start-up pioneering the development of light-speed optical coprocessors, today announced the company raised 3.95 million U.S. dollars / 3.05 million British pounds from undisclosed angel […]

read more
Bio-IT World interviews Earlham Institute and Optalysys on using optical processing for genetic sequence alignment

Bio IT World interviewed the Earlham Institute and Optalysys in an article published on 18th September 2017, on how Optalysys’s optical computing technology is being applied to genetic sequence alignment.  This follows our recent joint press release, demonstration and presentation at the Genome 10k / Genome Science Conference on 29th-31st August 2017.   Click HERE to […]

read more
New video from Optalysys showing demonstration of latest prototype

Optalysys demonstrated its latest prototype at the Genome 10k/Genome Science conference on 29th to 31st August 2017 in Norwich, UK. The video shows the technology housed in a desktop computer performing genomic sequence alignment. At the conference, Optalysys collaboration partner, the Earlham Institute, presented the latest test results on the accuracy of the technology where […]

read more
Optalysys and The Earlham Institute Demonstrate Results of Breakthrough Optical Processing for Sequence Alignment

Prototype Technology to Advance and Democratize High-Performance Genomic Research NORWICH, U.K. – 30 August 2017—Optalysys Ltd. (@Optalysys), a start-up pioneering the development of light-speed optical co-processors, will demonstrate the latest prototype of its breakthrough technology for genomic searching at the Genome 10k / Genome Science conference. Optalysys partner, The Earlham Institute (EI), will present the […]

read more